FORT LAUDERDALE, FL - January 22, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has released an educational ...

For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...

Together with robust data-driven modeling, rethinking regulation and data use could push forward a notoriously challenging ...

Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, received an up to $21M award to lead a project to develop next-generation models of drug toxicity to advance safer ...

Google gave an update on how it is using AI to advance science and build products at its recent Check Up event. In a blog post, Google's chief health officer, Dr. Karen DeSalvo, said that since the ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI)[1] models in drug development and in regulatory submissions titled, ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

LOS ANGELES, CA - January 15, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has released ...

In April, the US Food & Drug Administration (FDA) announced its decision to phase out animal testing requirements for ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...